- $3.50bn
- $7.03bn
- $4.22bn
- 70
- 88
- 98
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Net Property, Plant And Equipment | 66.5 | 54.7 | 48.2 | 46.6 | 85.3 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 33,631 | 35,340 | 36,204 | 33,133 | 35,103 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 28,954 | 29,856 | 30,945 | 31,364 | 32,887 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 4,677 | 5,484 | 5,260 | 1,769 | 2,216 |
Total Liabilities & Shareholders' Equity | 33,631 | 35,340 | 36,204 | 33,133 | 35,103 |
Total Common Shares Outstanding |